DUOPA

Peak

carbidopa and levodopa

NDAENTERALSUSPENSION
Approved
Jan 2015
Lifecycle
Peak
Competitive Pressure
30/100
Clinical Trials
2

Mechanism of Action

DOPA Decarboxylase Inhibitors

Pharmacologic Class:

Aromatic Amino Acid Decarboxylation Inhibitor

Clinical Trials (2)

NCT02611713N/ACompleted

Observational Study Evaluating Long-Term Effectiveness of Duodopa/Duopa in Patients With Advanced Parkinson's Disease

Started Jan 2016
213 enrolled
Advanced Parkinson's Disease
NCT01533116Phase 1Completed

Effect of BIA 9-1067 at Steady-state on the Pharmacokinetics of Levodopa/Carbidopa and Levodopa/Benserazide

Started Mar 2009